Related Experiment Video
Updated: Jun 20, 2026

06:10
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Temporary right ventricular support with Impella Recover RD axial flow pump
Hiroshi Sugiki1, Kuniki Nakashima, Emmanuelle Vermes
1Department of Cardiothoracic Surgery, Henri Mondor Hospital, Créteil, France. Hsugiki@aol.com
Asian Cardiovascular & Thoracic Annals
|August 29, 2009
Summary
The Impella Recover RD device effectively supports patients with post-cardiotomy right ventricular failure, offering good hemodynamic support. However, mechanical reliability requires improvement for this temporary cardiac support solution.
Area of Science:
- Cardiology
- Medical Devices
- Cardiovascular Surgery
Background:
- Post-cardiotomy right ventricular failure is a significant complication with poor outcomes.
- Temporary mechanical circulatory support is crucial for managing this condition.
- The Impella Recover RD is a percutaneous ventricular assist device.
Purpose of the Study:
- To evaluate the safety and efficacy of the Impella Recover RD for temporary right ventricular support.
- To assess the outcomes of patients receiving the Impella Recover RD after cardiac surgery.
- To report preliminary clinical experience with this device.
Main Methods:
- Retrospective review of 7 patients receiving the Impella Recover RD from January 2007 to December 2007.
- Device implantation for temporary support after heart transplantation, mitral valve replacement, or with a left ventricular assist device.
- Analysis of hemodynamic parameters, duration of support, and patient outcomes.
Main Results:
- Effective hemodynamic support was achieved in all patients, with significant reduction in central venous pressure.
- Mean duration of support was 4.9 days; 3 patients were successfully weaned and explanted.
- Complications included pump dysfunction in 2 patients and mortality due to recurrent failure or sepsis.
Conclusions:
- The Impella Recover RD demonstrates effectiveness in providing temporary right ventricular support.
- The device is easily implanted and explanted, often without cardiopulmonary bypass.
- Improvements in mechanical reliability are necessary for wider clinical adoption.
